Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants.
Affiliation
Department of Neonatology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada. afif_faisal@hotmail.comIssue Date
2011-03MeSH
Biological MarkersBirth Weight
Developmental Disabilities
Disability Evaluation
Ductus Arteriosus, Patent
Epidemiologic Methods
Female
Gestational Age
Humans
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases
Male
Natriuretic Peptide, Brain
Peptide Fragments
Prognosis
Troponin T
Metadata
Show full item recordCitation
Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. 2011, 96 (2):F133-7 Arch. Dis. Child. Fetal Neonatal Ed.Journal
Archives of disease in childhood. Fetal and neonatal editionDOI
10.1136/adc.2010.185967PubMed ID
21071684Additional Links
http://www.ncbi.nlm.nih.gov/pubmed/?term=21071684Abstract
There is little consensus regarding the use of echocardiography in patent ductus arteriosus (PDA) treatment in preterm infants. The use of troponin T (cTnT) and N-terminal Pro-BNP (NTpBNP) in combination with echocardiography assessment may facilitate the development of a superior predictive model.Item Type
ArticleLanguage
enISSN
1468-2052Sponsors
The National Maternity Hospital Research Fundae974a485f413a2113503eed53cd6c53
10.1136/adc.2010.185967